BRIEF published on 12/02/2025 at 10:15, 9 months 10 days ago Arvato and Geek+ Enhance Polish Logistics with Robotics Logistics Efficiency E-commerce Growth Warehouse Robotics Flexible Automation Rack-To-Person Technology
BRIEF published on 12/02/2025 at 10:15, 9 months 10 days ago Arvato et Geek+ améliorent la logistique polonaise grâce à la robotique Efficacité Logistique Croissance Du Commerce Électronique Robotique D'entrepôt Automatisation Flexible Technologie Rack-To-Person
BRIEF published on 12/02/2025 at 10:10, 9 months 10 days ago PepsiCo Forms Global Partnership with Mercedes-AMG Petronas F1 Team for 2026 Brand Collaboration Sports Marketing FORMULA 1 PepsiCo Partnership Mercedes-AMG Petronas
BRIEF published on 12/02/2025 at 10:10, 9 months 10 days ago PepsiCo conclut un partenariat mondial avec l'écurie Mercedes-AMG Petronas F1 pour 2026 Collaboration De Marque Marketing Sportif FORMULE 1 Mercedes-AMG Petronas Partenariat Avec PepsiCo
BRIEF published on 12/02/2025 at 10:09, 9 months 10 days ago CEOTRONICS AG Reports Increase in Turnover for First Half of 2025/2026 Order Backlog CeoTronics AG Turnover Increase Fiscal Report Defense Spending
BRIEF published on 12/02/2025 at 10:09, 9 months 10 days ago CEOTRONICS AG annonce une hausse de son chiffre d'affaires pour le premier semestre 2025/2026 Rapport Financier CeoTronics AG Augmentation Du Chiffre D'affaires Carnet De Commandes Dépenses De Défense
BRIEF published on 12/02/2025 at 10:05, 9 months 10 days ago Tacalyx Appoints Jean Engela as CEO to Drive Growth CEO Appointment Tacalyx Cancer Therapies Biotech Growth Jean Engela
BRIEF published on 12/02/2025 at 10:05, 9 months 10 days ago Tacalyx nomme Jean Engela PDG pour stimuler sa croissance Nomination Du PDG Tacalyx Thérapies Contre Le Cancer Jean Engela Croissance Des Biotechnologies
BRIEF published on 12/02/2025 at 10:05, 9 months 10 days ago Rentschler Biopharma and Coriolis Pharma Form Strategic Partnership Strategic Collaboration Biopharmaceutical Solutions Reduced Complexity Accelerated Timelines Integrated Expertise
BRIEF published on 12/02/2025 at 10:05, 9 months 10 days ago Rentschler Biopharma et Coriolis Pharma forment un partenariat stratégique Collaboration Stratégique Solutions Biopharmaceutiques Complexité Réduite Délais Accélérés Expertise Intégrée
Published on 09/12/2026 at 02:35, 1 day 1 hour ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 5 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 6 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 11 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 10 hours 33 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 20 hours 53 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 6 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 6 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 8 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 21 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 21 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 8 hours ago Availability of the 2026 Interim Financial Report
